Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1822 of 5804
-
New rapid test could speed up tropical fever diagnosis
Diagnosis ENROLLING_BY_INVITATIONThis is a multi-site, observational, cross-sectional clinical study that includes geographically diverse sites within and outside the United States.
Sponsor: Cepheid • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC
-
New hearing device for teens: can it restore sound?
Disease control Recruiting nowThis study is a post-market, multicentre, prospective, single arm investigation aimed to systematically collect safety and performance data on the Sentio system, when used as intended for adolescents (12-17 years inclusive).
Sponsor: Oticon Medical • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI could predict patient crashes before they happen
Knowledge-focused OngoingIn the event of illness or injury, patients are medically evaluated and initially treated in acute medical outpatient clinics, emergency rooms and surgeries. If medically indicated, care and treatment can also be provided in hospital. Depending on the severity of the illness and …
Sponsor: Kepler University Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:42 UTC
-
Do surgical glues really prevent brain fluid leaks? new trial aims to find out
Disease control Recruiting nowPostoperative cerebrospinal fluid (CSF) leak is a significant complication of endoscopic endonasal approaches (EEA) to the skull base. The use of tissue sealants such as fibrin glue (Tisseel) or synthetic agents (PEI/PEG) is widespread in surgical practice, however, recent high-q…
Phase: NA • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug combo targets tough blood cancers in early trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of SM08502 (cirtuvivint) alone and in combination with ASTX727 in treating patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Cirtuvivint may stop the growth of cancer cells by blocking …
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Hidden high blood pressure culprit targeted by new biomarker hunt
Knowledge-focused Recruiting nowPrimary aldosteronism is a prevalent yet underdiagnosed cause of secondary hypertension, contributing to significant cardiovascular morbidity and renal dysfunction. Despite affecting up to 20% of hypertensive patients, PA is frequently missed because it lacks distinctive clinical…
Sponsor: Peking University First Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
New blood test may spot liver cancer earlier in hepatitis c patients
Diagnosis CompletedThis study evaluates a target population of patients with Hepatitis C virus (HCV) infection, including those with complications like liver cirrhosis (LC) and hepatocellular carcinoma (HCC), to investigate the diagnostic utility of a specific panel of microRNAs (miRNAs). The inter…
Sponsor: Benha University • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Could a High-Fat, Low-Carb diet help men breathe easier with COPD?
Disease control CompletedChronic obstructive pulmonary disease (COPD) is associated with persistent airflow limitation, systemic inflammation, reduced exercise capacity, and unfavorable changes in body composition. Nutritional interventions may represent a complementary strategy to improve clinical outco…
Phase: NA • Sponsor: Agri Ibrahim Cecen University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New pill could cool menopause hot flashes without hormones
Symptom relief Recruiting nowThis Randomized Clinical Trial entitled Safety and Efficacy of a Peripherally Restricted Selective Kappa Agonist for Moderate to Severe Menopausal Symptoms in Midlife Women is a Phase 2a randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of asim…
Phase: PHASE2 • Sponsor: Tioga Pharmaceuticals • Aim: Symptom relief
Last updated Jun 26, 2026 14:24 UTC
-
New eye drug trial hopes to slow vision loss from dry AMD
Disease control Recruiting nowAge-related macular degeneration (AMD) is the abnormal growth of new blood vessels in the light-sensitive tissue at the back of the eye called the retina. Geographic Atrophy (GA) is an advanced form of dry AMD. The purpose of this study is to assess the adverse events and how int…
Phase: PHASE1, PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could a High-Fat diet lift bipolar depression?
Symptom relief Recruiting nowThe purpose of this study is to assess the clinical correlates of therapeutic precision ketosis in bipolar depression and to evaluate the cardiometabolic correlates associated with therapeutic precision ketosis in bipolar depression.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Toddler talk time: early coaching for deaf kids may pay off years later
Knowledge-focused ENROLLING_BY_INVITATIONThe overall goal of this randomized clinical trial is to learn about the effects of a parent-mediated intervention (PMI) designed to support communication outcomes for deaf and hard-of-hearing (DHH) children. Previously, the investigators enrolled 96 DHH children between 12 and 1…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Can a phone app train your brain to beat the blues?
Symptom relief Recruiting nowStudy will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal c…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
RSV shot for moms: does it shield newborns?
Prevention OngoingThis Pfizer-sponsored real-world retrospective non-interventional study will be conducted within a research network comprised of independent hospitals across Australia using data collected during routine standard of care clinical encounters available in health records, supplement…
Sponsor: Pfizer • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
Lung cancer drug sotorasib tested in chinese patients
Disease control CompletedThe primary objective of this study is to characterize the safety profile of sotorasib.
Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Yoga may tame hypertension and sharpen the mind, trial hints
Disease control Recruiting nowThe objective of this study will be to analyze the effect of 16 weeks of Yoga training on cardiovascular, autonomic, mental health, and cognitive parameters in hypertensive individuals. This is a randomized, controlled clinical trial to be conducted with adults and elderly (40 ye…
Phase: NA • Sponsor: Universidade Federal de Santa Catarina • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Immunotherapy after Chemo-Radiation shows promise for lung cancer
Disease control CompletedThis is a retrospective, single-center study evaluating the effectiveness and safety of consolidative durvalumab after cCRT in LS-SCLC in real-world setting.
Sponsor: Anhui Shi, MD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New e. coli vaccine enters first human safety trial
⭐️ VACCINE ⭐️ Recruiting nowThis study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.
Phase: PHASE1 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:26 UTC
-
Weight loss drug + exercise: a Muscle-Saving combo?
Disease control Recruiting nowThe use of glucagon-like peptide receptor agonists (GLP-1 RAs) may have clinically important effects on skeletal muscle mass (SMM), and physical function. The effects of exercise training in conjunction with GLP-1 RA therapy on these outcomes has not been studied. Additionally, m…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo aims to boost red blood cells in kids with rare blood disorder
Disease control Recruiting nowThe primary objective of this study is to evaluate efficacy of danicopan as add-on treatment to ravulizumab or eculizumab as assessed by hemoglobin (Hgb) change from Baseline at Week 12 in pediatric participants with paroxysmal nocturnal hemoglobinuria (PNH) and clinically signif…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC